SCHEMBL7930901

SCHEMBL7930901

CN(C)OS(=O)(=O)N1CCN(c2ccnc(CCO)n2)CC1

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SORD Q00796 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29941725 0.75 SORD (1.00) SORD
SCHEMBL7047595 0.75 SORD (1.00) SORD
SCHEMBL6293157 0.73 TSHR (0.53) SORD
SCHEMBL6415372 0.71 SORD (0.46) SORD
SCHEMBL9450503 0.71 SORD (0.74) SORD
Hydrochloric Acid SCHEMBL9450505 0.70 SORD (0.72) SORD
SCHEMBL6293147 0.69 SORD (0.70) SORD
SCHEMBL6294637 0.69 SORD (0.60) SORD
SCHEMBL6293340 0.68 SORD (0.60) SORD
SCHEMBL6293374 0.67 SORD (0.52) SORD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294538-B1 ANTIDIABETIC AGENTS AND DIABETIC NEUROPATHY, TREATMENT WITH OXIDOREDUCTASE ENZYMES PFIZER INC. 2001-09-25 US disclosed